Frontotemporal dementia with trans-activation response DNA-binding protein 43 presenting with catatonic syndrome

2017 ◽  
Vol 38 (3) ◽  
pp. 281-287 ◽  
Author(s):  
Ryohei Watanabe ◽  
Ito Kawakami ◽  
Mitsumoto Onaya ◽  
Shinji Higashi ◽  
Nobutaka Arai ◽  
...  
2017 ◽  
Vol 44 (3-4) ◽  
pp. 144-152 ◽  
Author(s):  
Mara Bourbouli ◽  
Michael Rentzos ◽  
Anastasia Bougea ◽  
Vasiliki Zouvelou ◽  
Vasilios C. Constantinides ◽  
...  

Background: Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are nowadays recognized as spectrum disorders with a molecular link, the TAR DNA-binding protein 43 (TDP-43), rendering it a surrogate biomarker for these disorders. Methods: We measured cerebrospinal fluid (CSF) levels of TDP-43, beta-amyloid peptide with 42 amino acids (Aβ42), total tau protein (τT), and tau protein phosphorylated at threonine 181 (τP-181) in 32 patients with ALS, 51 patients with FTD, and 17 healthy controls. Double-sandwich commercial enzyme-linked immunosorbent assays were used for measurements. Results: Both ALS and FTD patients presented with higher TDP-43 and τT levels compared to the control group. The combination of biomarkers in the form of the TDP-43 × τT / τP-181 formula achieved the best discrimination between ALS or FTD and controls, with sensitivities and specificities >0.8. Conclusion: Combined analysis of TDP-43, τT, and τP-181 in CSF may be useful for the antemortem diagnosis of ALS and FTD.


Brain ◽  
2010 ◽  
Vol 133 (6) ◽  
pp. 1763-1771 ◽  
Author(s):  
Agnes L. Nishimura ◽  
Vera Župunski ◽  
Claire Troakes ◽  
Claudia Kathe ◽  
Pietro Fratta ◽  
...  

2010 ◽  
Vol 222 (03) ◽  
Author(s):  
S Degen ◽  
S Kuhfittig-Kulle ◽  
JH Schulte ◽  
F Westermann ◽  
A Schramm ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document